Can dietary intervention help in management of problem behaviors in dementia?

Journal of Nutrition, Health and Aging

Volumn 13, Issue 6, 2009, Pages 499-501

  Volicer, L ^a  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID; ATYPICAL ANTIPSYCHOTIC AGENT; CATECHOLAMINE; CHOLECYSTOKININ; ENKEPHALIN; EXCITATORY AMINO ACID; SEROTONIN; SEROTONIN UPTAKE INHIBITOR; SUBSTANCE P; TRYPTOPHAN; VASOPRESSIN; ANTIDEPRESSANT AGENT; SEROTONIN RECEPTOR;

AGGRESSION; ALZHEIMER DISEASE; APATHY; BEHAVIOR DISORDER; BEHAVIOR THERAPY; CLINICAL FEATURE; DEMENTIA; DIET SUPPLEMENTATION; EDITORIAL; EOSINOPHILIA MYALGIA SYNDROME; FOOD INTAKE; FUNCTIONAL STATUS; GENETIC POLYMORPHISM; HUMAN; IRRITABILITY; NONHUMAN; PRIORITY JOURNAL; PSYCHOSOCIAL CARE; QUALITY OF LIFE; SEROTONINERGIC SYSTEM; SOCIAL INTERACTION; BRAIN; DIET THERAPY; DRUG EFFECT; METABOLISM; PSYCHOLOGICAL ASPECT;

AGGRESSION; ANTIDEPRESSIVE AGENTS, SECOND-GENERATION; BRAIN; DEMENTIA; HUMANS; RECEPTORS, SEROTONIN; TRYPTOPHAN;

EID: 73449145725     PISSN: 12797707     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12603-009-0100-3     Document Type: Editorial

References (29)

1. Petrovic M, Hurt C, Collins D, Burns A, Camus V, Liperoti R, et al. Clustering of behavioral and psychological symptoms in dementia (BPSD): a European Alzheimer's disease consortium (EADC) study. Acta Clin Belg 2007;62:426-432.
2. Yeager CA, Hyer L. Apathy in dementia: relations with depression, functional competence, and quality of life. Psychol Rep 2008;102:718-722.
3. Clarke DE, van Reekum R, Simard M, Streiner DL, Conn D, Cohen T, Freedman M. Apathy in dementia: clinical and sociodelmographic correlates. Journal of Neuropsychiatry and Clinical Neuroscience 2008;20:337-347.
4. Raglio A, Bellelli G, Traficante D, Gianotti M, Ubezio MC, Villani D, Trabucchi M. Efficacy of music therapy in the treatment of behavioral and psychitric symptoms of dementia. Alzheimer Dis Assoc Disord 2008;22:158-162.
5. Staal JA, Sacks A, Matheis R, Collier L, Calia T, Hanif H, Kofman ES. The effects of Snoezelen (multi-sensory behavior therapy) and psychiatric care on agitation, apathy, and activities of daily living in dementia patients on a short term geriatric psychiatric inpatient unit. Int J Psychiatry Med 2007;37:357-370.
6. Volicer L, Bass EA, Luther SL. Agitation and resistiveness to care are two separate behavioral syndromes of dementia. Journal of the American Medical Directors Association 2007;8:527-532.
7. Siegel A, Bhatt S, Bhatt R, Zalcman SS. The neurobiological basis for development of pharmacological treatments of aggressive disorders. Curr Neuropharmacol 2007;5:135-147.
8. McCloskey MS, Ben-Zeev D, Lee R, Berman ME, Coccaro EF. Acute tryptophan depletion and self-injurious behavior in aggressive patients and healthy volunteers. Psychopharmacology (Berl) 2008.
9. Stadler C, Zepf FD, Demish L, Schmitt M, Landgraf M, Poustka F. Influence of rapid tryptophan depletion on laboratory-provoked aggression in children with ADHD. Neuropsychobiology 2007;56:104-110.
10. Fernstrom JD. Branched-chain amino acids and brain function. J Nutr 2005;135:1539S-1546S.
11. Wurtman RJ, Wurtman JJ, Regan MM, McDermott JM, Tsay RH, Breu JJ. Effects of normal meals rich in carbohydrates or proteins on plasma tryptophan and tyrosine ratios. Am J Clin Nutr 2008;77:128-132.
12. Badawy AAB, Morgan CJ, Davis NR, Dacey A. High-fat diets increase tryptophan availability to the brain: importance of choice of the control diet. Biochemical Journal Letters 1984;217:863-864.
13. Yamamoto T, Hirano A. Nucleus raphe dorsalis in Alzheimer's disease: neurofibrillary tangles and loss of large neurons. Ann Neurol 1985;17:573-577.
14. Lai MKP, Tsang SWY, Francis PT, Esiri MM, Keene J, Hope T, Chen CPLH. Reduced serotonin 5-HT1A receptor binding in the temporal cortex correlates with aggressive behavior in Alzheimer disease. Brain Res 2003;974:82-87.
15. Lanctôt KL, Herrmann N, Eryavec G, van Reekum R, Reed K, Naranjo CA. Central serotonergic activity is related to the aggressive behaviors of Alzheimer's disease. Neuropsychopharmacology 2002;27:646-654.
16. Assal F, Alarcon M, Solomon EC, Masterman D, Geschwind DH, Cummings JL. Association of the serotonin transporter and receptor gene polymorphism in neuropsychiatric symptoms in Alzheimer disease. Arch Neurol 2004;61:1249-1253.
17. Lam LC, Tang NL, Ma SL, Zhang W, Chiu HF. 5-HT2A T102C receptor polymorphism and neuropsychiatric symptoms in Alzheimer's disease. Int J Ger Psychiat 2004;19:523-526.
18. Pritchard AL, Harris J, Pritchard CW, Coates J, Hague S, Holder R, et al. Role of 5HT 2A and 5HT 2C polymorphisms in behavioral and psychological symptoms of Alzheimer's diesease. Neurobiol Aging 2008;29:341-347.
19. Ueki A, Ueno H, Sato N, Shinjo H, Morita Y. Serotonin transporter gene polymorphism and BPSD in mild Alzheimer's disease. Journal of Alzheimers Disease 2007;12:245-253.
20. Sukonick DL, Pollock BG, Sweet RA, Mulsant BH, Rosen J, Klunk WE, Kastango KB, DeKosky ST, Ferrell RE. The 5-HTTPR*S/*L polymorphism and aggressive behavior in Alzheimer disease. Arch Neurol 2001;58:1425-1428.
21. Pritchard AL, Pritchard CW, Bentham P, Lendon CL. Role of serotonin transporter polymorphisms in th behavioral and psychological symptoms in probable Alzheimer disease patients. Dement Geriatr Cogn Disord 2007;24:201-206.
22. Richards JB, Papaioannou A, Adachi JD, Joseph L, Whitson HE, Prior JC, et al. Effect of selective serotonin reuptake inhibitors on the risk of fracture. Arch Intern Med 2007;167:188-194.
23. Watson WA, Litovitz TL, Rodgers GC, et al. 2004 Annual report of the American Association of Poison Control Centers Toxic Exposure Surveillance System. American Journal of Emergency Medicine 2005;23:666.
24. Sultzer DL, Davis SM, Tariot PN, Dagerman KS, Lebowitz BD, Lyketsos CG, Rosenheck RA, Hsiao JK, Lieberman JA, Schneider LS, Catie-AD Study Group. Clinical symptom responses to atypical antipsychotic medications in Alzheimer's disease: phase 1 outcomes from the CATIE-AD effectiveness trial. Am J Psychiatry 2008;165:844-854.
25. U.S.Food and Drug Administration. Information paper on L-tryptophan and 5-hydroxy-L-tryptophan. vm.cfsan.fda.gov/-dms/ds-tryp1.html . 2001. 12-7-2008.
26. Hudson C, Hudson S, MacKenzie J. Protein-source of tryptophan as an efficacious treatment for social anxiety disorder: a pilot study. Canadian Journal of Physiology and Pharmacology 2007;85:928-932.
27. Markus CR, Olivier B, de Haan EH. Whey protein rich in alpha-lactalbumin increases the ratio of plasma tryptophan to the sum of the other large neutral amino acids and improves cognitive performance in stress-vulnerable subjects. Am J Clin Nutr 2002;75:1051-1056.
28. Kim, B. Healthy Foods That Promote Deep Sleep. http://chetday.com/foods deepsleep.htm . 2008. 12-10-2008.
29. The George Mateljan Foundation. The World's Healthies Foods. http://www.whfoods.com/genpage.php?tname=nutrient&dbid=103 . 2008. 12-10-2008.